| Financial Year |
March 31 2023 |
| Monetary Funds |
221,453,734.35 |
| Held-for-trading Financial Assets |
30,019,333.33 |
| Notes Receivable |
7,069,105.48 |
| Accounts Receivable |
197,613,538.65 |
| Advances to Suppliers |
8,700,946.08 |
| Other Receivables |
114,352,333.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
52,888,809.68 |
| Dividend Receivable |
-- |
| Inventories |
6,374,076.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
72,514,753.99 |
| Total Current Assets |
658,097,821.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
207,428,979.02 |
| Long-term Equity Investment |
728,991,926.61 |
| Investment Properties |
-- |
| Fixed Assetes |
4,775,227,820.85 |
| Under-construction Projects |
242,842,812.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,196,149,280.47 |
| R&D expenses |
2,517,907.83 |
| Goodwill |
415,701,790.65 |
| Long-Term Deferred and Prepaid Expenses |
99,484,471.25 |
| Deferred Income Tax Assets |
88,437,972.17 |
| Other Non-Current Assets |
27,878,191.45 |
| Sub-Total of Non-Current Assets |
7,843,453,230.66 |
| Total Assets |
8,501,551,052.21 |
| Short-Term Loans |
283,346,066.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
62,782,452.92 |
| Accounts Received In Advance |
3,362.00 |
| Employee Compensation Payable |
13,198,762.35 |
| Taxes Payable |
36,708,802.89 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
106,588,089.98 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
544,955,931.53 |
| Other Current Liabilities |
1,405,204.47 |
| Sub-Total of Current Liabilities |
1,065,045,376.67 |
| Long-term Loans |
3,787,314,129.44 |
| Bonds Payable |
598,004,437.78 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
176,579,478.15 |
| Other Non-Current Liabilities |
217,010.40 |
| Sub-Total of Non-Current Liabilities |
4,629,829,695.70 |
| Total Liabilities |
5,694,875,072.37 |
| Paid-In Capital(Or Share Stock) |
452,237,080.00 |
| Capital Surplus |
882,551,348.78 |
| Surplus Reserve |
92,595,001.91 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
911,273,798.94 |
| Minority Stockholder's Interest |
352,288,260.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,454,387,719.52 |
| Owner's Equity（Stockholder's Equity） |
2,806,675,979.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,501,551,052.21 |
